In 2024, Dr Reddy's Laboratories completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Dr Reddy's Laboratories has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2024, the total operational greenhouse gas (GHG) emissions of Dr Reddy's Laboratories amounted to 304,185 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Dr Reddy's Laboratories decreased by 13.56%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2024, the total Scope 1 emissions of Dr Reddy's Laboratories were 189,530 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2021, Dr Reddy's Laboratories's Scope 1 emissions have decreased by 45.84%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Dr Reddy's Laboratories's Scope 1 emissions decreased by 11.54%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
In 2024, Dr Reddy's Laboratories reported Scope 2 greenhouse gas (GHG) emissions of 114,655 tCOâ‚‚e using the location-based method.
Since 2021, Dr Reddy's Laboratories's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 35.39%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Dr Reddy's Laboratories's Scope 2 emissions (Location-Based) fell by 16.69% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
In 2024, Dr Reddy's Laboratories reported its Scope 2 emissions using the location-based method.
In 2024, Dr Reddy's Laboratories reported 866,992 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Dr Reddy's Laboratories includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
In 2024, Dr Reddy's Laboratories reported total Scope 3 emissions of 866,992 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 85.39% of these emissions originated from upstream activities such as purchased goods and capital goods, while 14.61% came from downstream activities like product use, distribution, and end-of-life treatment.
Since 2021, Dr Reddy's Laboratories's Scope 3 emissions have increased by 83.85%, reflecting a rising long-term trend in Scope 3 emissions over time.
Compared to the previous year (2023), Dr Reddy's Laboratories's Scope 3 emissions remained relatively stable, indicating that Dr Reddy's Laboratories 's emissions have plateaued with no significant change in its value chain footprint.
In 2024, Dr Reddy's Laboratories reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2024, the largest contributors to Dr Reddy's Laboratories's Scope 3 emissions were:
In 2024, Dr Reddy's Laboratories reported a total carbon footprint of 1,171,177 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 7.99% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Dr Reddy's Laboratories's total carbon footprint was Scope 3 emissions, accounting for 74.03% of the company's total carbon footprint, followed by Scope 1 emissions at 16.18%.